News: Hospira, Inc. (HSP.N)

HSP.N on New York Stock Exchange

49.01USD
1:34pm EST
Price Change (% chg)

$0.71 (+1.47%)
Prev Close
$48.30
Open
$48.23
Day's High
$49.01
Day's Low
$48.21
Volume
79,600
Avg. Vol
835,301
52-wk High
$49.90
52-wk Low
$21.21

view news for:
Select another date:

Wed, Dec 16 2009

Indian shares up 0.2 pct; Infosys hits record high

* Banks drop on worry cbank may tighten policy (Updates to close)

Continue Reading

Indian shares edge down; banks fall, Infosys up

* Infosys up as official says better revenue growth in FY11

UPDATE 1-Hospira to buy Orchid generic injectable business

* $400 mln deal includes India manufacturing, R&D facility

UPDATE 4-Steel, rubber found in some Genzyme drugs

* Genzyme shares drop more than 7 percent (Updates with comments from company, analysts, FDA)

UPDATE 2-Fresenius Q3 profit up on higher generic drug sales

* Q3 adjusted net income 128 mln euros, vs forecast 123 mln

UPDATE 2-Hospira Q3 tops estimates; boosts outlook

* Adjusted Q3 profit beats analysts' consensus by 21 cents

UPDATE 3-U.S. FDA probing Abbott, Hospira device cords

* Risks include electrical shock, death - FDA (Adds Abbott comments)

Seoul shares seen up; eyes on BOK, LG Telecom

SEOUL, Oct 9 (Reuters) - Seoul shares may rise on Friday after gains overnight on Wall Street, but gains could be limited by caution before the Bank of Korea's interest rate decision and comments, with eyes also on the won <KRW=>.

UPDATE 1-Hospira in deal with Celltrion on biogenerics

* Deal on biogenerics in US, Europe, Australia, Canada, NZ

HEADLINE STOCKS-Some U.S. stocks on the move on Sept. 30

(Updates to add Hospira/Teva, ImmuCell, Orexigen, Omnova)

Select another date:

Market Views

» More HSP.N Market Views

Press Releases

view news for: